GALECTIN THERAPEUTICS INC GALT
CIK 0001133416
Form 4 transactions dated Sep 1, 2023 to Sep 23, 2026, as reported to the SEC.
Insider purchases & sales
- Purchased
- $139.79K
- Sold
- $6.46M
Sep 1, 2023 – Aug 4, 2026
Available records · partial months are marked ·
| Date | Insider | Activity | Trade value (USD) | % of prior holding | |
|---|---|---|---|---|---|
| 2026-07-14 | Jamil Khurram Chief Medical Officer | Sale10b5-1 footnote | $83.28K 16,250 shares sold | 100.00% sold Direct holding | ▾ |
| 2026-06-29 | Shlevin Harold H. Director | Sale10b5-1 footnote | $112.23K 22,268 shares sold | 77.41% sold Direct holding | ▾ |
| 2026-06-29 | Jamil Khurram Chief Medical Officer | Sale10b5-1 footnote | $239.23K 47,467 shares sold | 100.00% sold Direct holding | ▾ |
| 2026-06-26 | Shlevin Harold H. Director | Sale10b5-1 footnote | $38.66K 7,732 shares sold | 54.33% sold Direct holding | ▾ |
| 2026-06-26 | Jamil Khurram Chief Medical Officer | Sale10b5-1 footnote | $22.85K 4,570 shares sold | Unavailable Direct holding | ▾ |
| 2026-06-23 | Jamil Khurram Chief Medical Officer | Sale10b5-1 footnote | $23.73K 7,557 shares sold | 100.00% sold Direct holding | ▾ |
| 2026-05-26 | Jamil Khurram Chief Medical Officer | Sale10b5-1 footnote | $1.76K 568 shares sold | 100.00% sold Direct holding | ▾ |
| 2026-02-06 | ELDRED KARY Director | Purchase | $810.00 300 shares bought | 0.46% added Direct holding | ▾ |
| 2026-01-06 | LEWIS JOEL President and CEO · Director | Sale10b5-1 footnote | $134.85K 37,698 shares sold | 4.33% sold Direct holding | ▾ |
| 2026-01-06 | CALLICUTT JACK W Chief Financial Officer | Sale10b5-1 footnote | $74.70K 20,354 shares sold | 72.78% sold Direct holding | ▾ |
Showing 17 / 17 record groups in 2026. The complete set is available through the API.
Follow the people behind the trades.
Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and reach other datasets through the Akkru API.
- Download CSV
- Earlier filings
- Advanced screening & filtering
- API & AI access
＋ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. For the year shown, this page lists 17 of 17 purchase / sale groups and 30 of 41 other groups; the totals and the monthly series cover the whole window.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.
MCP https://api.akkrudata.ai/mcp
list_insider_transactions
{"ticker":"GALT","transaction_code":["P","S"],"transaction_form_type":"4","page_size":20}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.